Greetings! By delivering this special New Year Edition of the OncoWuXi Newsletter, we would like to extend our sincere appreciation for your continued interest in OncoWuXi database, and wish you a happy, healthy and prosperous New Year! This Special Edition will bring you our full-year database overview on target identification and validation, biomarker, targeted oncology, immuno-oncology, and immunology platforms. It has been our pleasure to collaborate with you throughout the year and with a deep gratitude for your continued trust and support, we look forward to serving you again in 2022!

CRISPR/Cas9 library-based in vitro & in vivo screening 280+ CDX models in mouse 20+ CDX models in rat 30+ Orthotopic models 30+ Metastasis models 1300+ PDX models 90+ Drug-resistant models 40+ Autoimmune disease models GEAM & AAV packaging Rare genetic disease models

70+ Syngeneic models 70+ Humanized models 30+ Immune assays NHP translation Center Multiplex pathology analysis NanoString, scRNAseq, spatial transcriptomics platform CAP Pathology & FACS lab 200+ Clinical biomarkers